jagomart
digital resources
picture1_Insurance Pdf 43938 | 11 Questions On General Insurance Pricing


 149x       Filetype PDF       File size 0.11 MB       Source: assets.kpmg


File: Insurance Pdf 43938 | 11 Questions On General Insurance Pricing
margin margin m cro n ar rksi g a g p i m mar n p m a cro rks 11 questions on general insurance pricing answered kpmg com uk ...

icon picture PDF Filetype PDF | Posted on 17 Aug 2022 | 3 years ago
Partial capture of text on file.
       MARGIN                                                                                                           MARGIN
                                                                                                                                  M CRO
    N                                                                                                                             AR
  RKSI
    G
  A                                                                                                                               G P
                                                                                                                                  I  M
   MAR                                                                                                                            N
  P M                                                                                                                               A
  CRO                                                                                                                               RKS
                          11 questions on 
                          general insurance 
                          pricing, answered
                          kpmg.com/uk/futureinsurance
                          August 2019
                                                                                                                                    CRO
  RKS
                                                                                                                                    P
  A                                                                                                                               M  M
   MN                                                                                                                             ARA
  P I           © 2019 KPMG LLP, a UK limited liability partnership and a member firm of the KPMG network of independent member firms affiliated with 
    G           KPMG International Cooperative (“KPMG International”), a Swiss entity.  All rights reserved.         0              RKS
                                                                                                                                  G
                                                                                                                                  I
  CROAR                                                                                                                           N
    M
       MARGIN                                                                                                           MARGIN
        MARGIN                                                                                                                    MARGIN
                                                                                                                                             M CRO
    N                                                                                                                                        AR
  RKSI
    G
  A                                                                                                                                          G P
                                                                                                                                             I  M
   MAR                                                                                                                                       N
  P M                                                                                                                                          A
  CRO                                      11 questions on general                                                                             RKS
                                           insurance pricing, answered
                 Methods of pricing in general insurance has become ever more sophisticated. Technology and growing access 
                 to rich sources of data has brought greater efficiencies and commercial benefits for insurers.
                 As a result, there is increasing attention from the regulator and customers – insurers are asking more questions 
                 around how can they work to better understand the drivers of poor outcomes, develop a clear action plan and 
                 ensure senior management buy-in to address the increasing regulatory, government and media pressure. 
                 Now is the time to act. We’ve compiled a list of the 11 of the most common questions posed to us by a host of 
                 roles across insurance; from those concerned about commerciality to regulatory professionals. 
                            Has the FCA considered educating                         What do you think this means for the 
                     1      consumers in the same way to what                3       future trends in the personal lines 
                            Ofgemhas done with their pricing?                        market? If prices are already high, surely 
                            The Financial Services Conduct Authority (FCA)           equalisation will push prices up?
                            does not have a remit to educate consumers. In           If the competitive conditions for loyal 
                            the UK, this role is filled by the Money Advice          customers are unchanged, a remedy requiring 
                            Service (MAS). However, the FCA will seek to             parity between new and renewal pricing could 
                            improve consumers’ understanding of the                  lead to new business prices rising to renewal 
                            industry through its interim and final reports,          levels, resulting in prices overall increasing for 
                            and through press releases to encourage the              consumers. This dynamic occurred when 
                            media and other commentators to help the                 Ofcombanned price discrimination in a sunset 
                            general public’s understanding.                          clause in energy markets.
                            We have observed a range of regulatory                   If renewal prices are a concern for the FCA, we 
                            attempts to increase consumer awareness of               would not therefore expect a remedy designed 
                            pricing practices, such as the publication of            to equalise prices to be used in isolation; we 
                            value measures and displaying last year’s                would expect the FCA to adopt a broader 
                            premium on the renewal invitation. It is                 package of remedies in order to avoid this type 
                            arguable whether these interventions have led            of unintended consequence.
                            to material change in customer understanding 
                            and/or engagement.
                            How will pricing optimisation tools be                   Are some business lines more 
                    2       used in the future?                              4       predisposed to this issue and why?
                            There are a range of possible outcomes for the           By definition, the loyalty penalty is considered 
                            use of optimisation techniques and tools in the          to impact long-standing customers and certain 
                            future. It is possible that the FCA conclude that        product lines (most notably home insurance) 
                            some of the concerns in relation to customer             are more likely to have a greater proportion of 
                            outcomes from pricing could be caused by                 long-standing customers than others (e.g. 
                            optimisation techniques and therefore controls           motor) due to differences in the level of 
                            over their use are possible. However, they are           shopping around and use of price comparison 
                            likely to balance that with the perspective that         websites. However, it is important to recognise
                            the use of data and modelling capability can be          that poor outcomes from pricing can be caused 
                            a benefit to competition and banning such                by a range of drivers such as the extent of data 
                            approaches might lead to unintended                      used in pricing and other product lines might be 
                            consequences. It is likely, therefore, that firms        more exposed here. 
                            are encouraged to ensure their controls over             Whilst much of the focus is on personal lines 
                            the use of optimisation are sufficiently well            products, we do believe there is potential for 
                            developed and customer outcomes monitored                read across into other sectors, not least SME 
                            to mitigate risks to customer outcomes.                  products, where there is precedent for FCA 
                                                                                     concerns over the fair treatment of customers.
                                                                                                                                               CRO
  RKS
                                                                                                                                               P
  A                                                                                                                                          M  M
   MN                                                                                                                                        ARA
  P I            © 2019 KPMG LLP, a UK limited liability partnership and a member firm of the KPMG network of independent member firms affiliated with 
    G            KPMG International Cooperative (“KPMG International”), a Swiss entity.  All rights reserved.                  1               RKS
                                                                                                                                             G
                                                                                                                                             I
  CROAR                                                                                                                                      N
    M
        MARGIN                                                                                                                    MARGIN
         MARGIN                                                                                                                                                  MARGIN
                                                                                                                                                                              M CRO
     N                                                                                                                                                                        AR
   RKSI
     G
   A                                                                                                                                                                          G P
                                                                                                                                                                              I  M
    MAR                                                                                                                                                                       N
   P M                                                                                                                                                                          A
   CRO                                                                                                                                                                          RKS
                                  Is there potential for FCA remedies to                               What is the expected impact of new 
                        5 affect overall profitability in the market?                         7        business verses renewal price parity on 
                                  The potential certainly exists, but this not only                    distribution channels? Could this parity 
                                  depends on the types of remedies the FCA                             lead to higher commission channels, 
                                  introduces, but also on supply-side responses                        inevitably resulting in higher prices and 
                                  by insurance firms and intermediaries, and                           higher commission channels and 
                                  finally on demand-side responses by                                  therefore higher-end prices for 
                                  customers. For example, if the remedies target                       consumers?
                                  ‘high’ prices charged to vulnerable customers                        If the competitive conditions for loyal 
                                  and – crucially – assuming there are no knock-                       customers are unchanged, a remedy requiring 
                                  on effects in the industry then we would                             parity between new and renewal pricing could 
                                  expect profitability to fall. By contrast, remedies                  lead to new business prices rising to renewal 
                                  that seek to reduce or end the loyalty penalty                       levels, resulting in prices overall increasing for 
                                  could result in front-book pricing increasing,                       consumers. This dynamic occurred when 
                                  with the overall effect on profitability                             Ofcombanned price discrimination in a sunset 
                                  ambiguous and potentially increasing.                                clause in energy markets.
                                  We note that the FCA will undertake an 
                                  economic profitability analysis, and the results 
                                  of that analysis will inform the type and design                       What types of data do you think the 
                                  of any remedies adopted. If, for example,                              FCA find more or less acceptable for 
                                  profitability in the industry is found to be high,           8         consumer pricing? Is it about 
                                  the FCA would expect any remedies they adopt                           transparency or does the issue lie with 
                                  to reduce profitability. In contrast, if the FCA                       how relevant said data is to the 
                                  does not find evidence of excess profitability,                        consumer?
                                  then the remedies may not be specifically 
                                  targeted in such a way as to reduce profitability,                     The FCA are likely to find the use of data on 
                                  although profitability could still be inadvertently                    protected characteristics, or other metrics 
                                  reduced, depending on how the market                                   which specifically identify vulnerable 
                                  responds to the remedies.                                              consumers, to be more problematic where 
                                  How pragmatic will the FCA be around                                   those data are used to charge higher prices, 
                                                                                                         particularly where there can be no objective 
                        6 the detailed data needed to identify                                           justification for those higher prices from a risk 
                                  vulnerable customers, and therefore the                                perspective.
                                  ability of insurers to know if a customer 
                                  is vulnerable?
                                  The FCA requested a lot of data from insurance                        Will price control really work due to 
                                  companies during this market study, and also                9         the variation of underwriting risks and 
                                  has access to third party data sets that could be                     rising claims inflation in the market?
                                  used to provide further information on                                In principle the insurance industry is not well-
                                  customer vulnerability. So the FCA already has                        suited to price controls given that pricing and 
                                  access to detailed data. The key question for us                      coverage is customer-specific, and that both 
                                  is how the FCA will try to define vulnerability in                    risk and personal circumstances change over 
                                  the face of practical difficulties such as the                        time. Price controls are normally regarded as 
                                  possibility of firms appealing the definition,                        being more suited to industries selling 
                                  customers objecting to being classified as                            homogenous products and with identical 
                                  ‘vulnerable’, customers’ circumstances                                prices/tariffs being charged to all or large 
                                  changing over their lifetime, and the possibility                     segments of customers.
                                  that a broad definition would lead to wide and                        However, the CMA (Competition and Markets 
                                  disruptive remedies that the FCA may shy a                            Authority) has given a strong steer to the FCA 
                                  way from.                                                             that all remedies, including price controls, 
                                                                                                        should be considered, so we expect the FCA 
                                                                                                        to consider very carefully whether such a 
                                                                                                        remedy is required, and if so, how some of 
                                                                                                        the practical challenges of implementing such 
                                                                                                        a remedy could be addressed
                                                                                                                                                                                CRO
   RKS
                                                                                                                                                                                P
   A                                                                                                                                                                          M  M
    MN                                                                                                                                                                        ARA
   P I               © 2019 KPMG LLP, a UK limited liability partnership and a member firm of the KPMG network of independent member firms affiliated with 
     G               KPMG International Cooperative (“KPMG International”), a Swiss entity.  All rights reserved.                                            2                  RKS
                                                                                                                                                                              G
                                                                                                                                                                              I
   CROAR                                                                                                                                                                      N
     M
         MARGIN                                                                                                                                                  MARGIN
                            What interplay is there on this matter between the CMA and the FCA?
                            The CMA has responded to the Citizens Advice super-complaint with recommendations to regulators on 
                   10       addressing the loyalty penalty. The FCA and CMA are likely to have had some discussions regarding remedies 
                            and defining vulnerability (in particular because any practical/quantitative definition is likely to be precedent-
                            setting), but the FCA will be responsible for the remedies. The FCA is also part of the “loyalty penalty working 
                            group”, set-up by the CMA following its investigation into the Citizens Advice super-complaint. This working 
                            group reported on progress in June 2019, and the CMA is due to publish a further update on progress by the 
                            end of 2019.
                            Defining a vulnerable customer feels impossible, especially when a customer’s circumstances 
                   11       could change over the life of a policy
                            The FCA requested a lot of data from insurance companies during this market study, and also has access to 
                            third party data sets that could be used to provide further information on customer vulnerability. So the FCA 
                            already has access to detailed data. The key question for us is how the FCA will try to define vulnerability in the 
                            face of practical difficulties such as the possibility of firms appealing the definition, customers objecting to being 
                            classified as ‘vulnerable’, customers’ circumstances changing over their lifetime, and the possibility that a broad 
                            definition would lead to wide and disruptive remedies that the FCA may shy away from.
                            We know there is no ‘question and answer’ approach that can spark meaningful change but the questions alone 
                            reveal the sheer scope and complexity of the issue posed to the regulators and industry today. Insurers can see 
                            this as a regulatory hurdle or a chance for the industry to reinvent itself and regain consumer trust. It’s a time 
                            for action. Find out more kpmg.com/uk/futureinsurance or contact our specialists direct
                            CMA following its investigation into the Citizens Advice super-complaint. This working group reported on 
                            progress in June 2019, and the CMA is due to publish a further update on progress by the end of 2019.
                 Contacts
                               David Lennon                                    James Hillon
                               Director, Regulatory Risk                       Director, Risk Consulting 
                               KPMG LLP                                        KPMG LLP
                               +44 (0) 7585 401 164                            +44 (0) 7468 351 269
                               dave.lennon@kpmg.co.uk                          james.hillon@kpmg.co.uk
                               Jenny Sugiarto                                  Gordon Cookson
                               Director, Economics                             Associate Director, Economics
                               KPMG LLP                                        KPMG LLP
                               +44 (0) 7827 308 572                            +44 (0) 7775 019 100
                               jenny.sugiarto@kpmg.co.uk                       gordon.cookson@kpmg.co.uk
                 kpmg.com/uk              The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. 
                                          Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it 
                                          is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice 
                                          after a thorough examination of the particular situation.
                                          © 2019 KPMG LLP, a UK limited liability partnership and a member firm of the KPMG network of independent member firms affiliated with 
                                          KPMG International Cooperative (“KPMG International”), a Swiss entity.  All rights reserved.
                                          The KPMG name and logo are registered trademarks or trademarks of KPMG International. | CREATE: CRT118223A
The words contained in this file might help you see if this file matches what you are looking for:

...Margin m cro n ar rksi g a p i mar rks questions on general insurance pricing answered kpmg com uk futureinsurance august mn ara llp limited liability partnership and member firm of the network independent firms affiliated with international cooperative swiss entity all rights reserved croar methods in has become ever more sophisticated technology growing access to rich sources data brought greater efficiencies commercial benefits for insurers as result there is increasing attention from regulator customers are asking around how can they work better understand drivers poor outcomes develop clear action plan ensure senior management buy address regulatory government media pressure now time act we ve compiled list most common posed us by host roles across those concerned about commerciality professionals fca considered educating what do you think this means consumers same way future trends personal lines ofgemhas done their market if prices already high surely financial services conduct ...

no reviews yet
Please Login to review.